Stochastic model of in-vivo X4 emergence during HIV infection: implications for the CCR5 inhibitor maraviroc.

by Borislav Savkovic, Geoff Symonds, John M Murray
Published 2012-01-01

23 Knockdown of CCR5 expression in antigen-specific cytotoxic CD4 T cells

by John Zaunders, Annett Howe, Scott Ledger, Anthony Kelleher, John Murray, Geoff Symonds
Published 2017-07-01

CCR5 Targeted Cell Therapy for HIV and Prevention of Viral Escape

by Gero Hütter, Josef Bodor, Scott Ledger, Maureen Boyd, Michelle Millington, Marlene Tsie, Geoff Symonds
Published 2015-07-01

A quantitative comparison of anti-HIV gene therapy delivered to hematopoietic stem cells versus CD4+ T cells.

by Borislav Savkovic, James Nichols, Donald Birkett, Tanya Applegate, Scott Ledger, Geoff Symonds, John M Murray
Published 2014-06-01

Numerical Investigation of the Resistance of a Zero-Emission Full-Scale Fast Catamaran in Shallow Water

by Guangyu Shi, Alexandros Priftis, Yan Xing-Kaeding, Evangelos Boulougouris, Apostolos D. Papanikolaou, Haibin Wang, Geoff Symonds
Published 2021-05-01

Block and Lock HIV Cure Strategies to Control the Latent Reservoir

by Chantelle L. Ahlenstiel, Geoff Symonds, Stephen J. Kent, Stephen J. Kent, Stephen J. Kent, Anthony D. Kelleher
Published 2020-08-01

Achieving HIV-1 Control through RNA-Directed Gene Regulation

by Vera Klemm, Jye Mitchell, Christina Cortez-Jugo, Francesca Cavalieri, Geoff Symonds, Frank Caruso, Anthony Dominic Kelleher, Chantelle Ahlenstiel
Published 2016-12-01

Promoter Targeting shRNA Suppresses HIV-1 Infection In vivo Through Transcriptional Gene Silencing

by Kazuo Suzuki, Shinichiro Hattori, Katherine Marks, Chantelle Ahlenstiel, Yosuke Maeda, Takaomi Ishida, Michelle Millington, Maureen Boyd, Geoff Symonds, David A Cooper, Seiji Okada, Anthony D Kelleher
Published 2013-01-01